mProbe – DIRECTOR, Business Development- Pharma Services

Company:  mProbe is a privately held company with its OncoPlex Diagnostics division focused on leveraging its Liquid Tissue® platform and enabling methods for the analysis of protein biomarkers in formalin fixed tissue and the development and commercialization of personalized medicine assays supporting cancer drug development and as clinical diagnostic assays. The company has developed a platform of proprietary technologies that make possible the accurate measurement of proteins in formalin fixed paraffin embedded (FFPE) tissue, the standard method used to preserve and store biopsies and surgical samples in medical research, clinical trials and pathology testing worldwide. OncoPlexDx has commercialized mass spectrometry based FFPE tissue protein quantitation assay services in support of pre-clinical drug development and in clinical trials of new cancer drugs.  OncoPlexDx offers proprietary clinical pathology assays that is offered through its CAP accredited, CLIA-certified diagnostic laboratory services.

 

Position:  The Director, Strategic Sales will be responsible for maintaining and growing existing client business and in developing new relationships with Pharmaceutical and biotech companies. S/he will have a lead role in driving the sales strategies and in growing the Company’s pharma business to generate revenue. This will also be responsible for meeting monthly, quarterly and yearly sales quotas and provide customer feedback to improve OPDX products and offerings to best meet market demands.  The position will report to the CEO.

The Company’s corporate headquarters are located in California, however this position can be a remote based role.

Key responsibilities:

 

  • Account development – identify and cultivate targeted new accounts, follow up on leads and prospects, maintain ongoing contacts with new and existing accounts, develop specific business proposals, lead the drafting of proposals and quotations, assume primary responsibility for revenue projections and updates and internal planning and coordination with clinical operations and general management.

 

  • Sales – Organize web-based and in-person customer visits, seminars and proposal development meetings, drawing in and coordinating with applicable personnel in the company as well as with respect to the appropriate decision makers and support personnel at the account.

 

  • Strategic Planning – Develop overall strategies and tactical plans in support of revenue development within assigned responsibilities.

 

  • Initiate new company contacts within pharmaceutical companies as well as academic and related institutes.

 

  • Build and leverage existing strategic networks and business relationships. Manage customer relations/satisfaction throughout collaboration including site visits.

 

  • Provide a direct, “hands-on” role to identify opportunities, and create contacts and interest with senior academic investigators, community oncology practitioners and program managers.

 

  • Work with CEO to create and execute a business development plan and account management process with ability to project revenue growth and track progress in generating new accounts and expanding business in existing relationships.

 

 

  • Report progress on a regular basis, associated with the acquisition of new opportunities for new and existing accounts.

 

  • Participate in company initiatives as required for securing new business and maintaining relationships with existing clients.

 

  • Attend and represent OncoPlexDx at selected industry meetings and conferences.

 

  • Structure relationships in which the company captures milestone fees for development of personalized medicine and companion diagnostics.

 

  • While the position is expected to initially involve a significant individual contribution utilizing support from the company’s existing marketing, operations and R&D management, the individual will be expected, long term, to plan and build a team to generate and support continued business growth.

Specifications:

  • Bachelor’s degree in relevant scientific or technical discipline, advanced degree preferred (MBA and/or PhD)

 

  • Minimum of (5) years successful sales/business development experience including with specific roles in companion diagnostics, personalized medicine and/or oncology/pathology diagnostics.

 

  • Prior successful accomplishments as the lead manager in selling oncology tests to community and academic oncologists.

 

  • Ability and willingness to travel approximately 50-75% of the time (international and domestic).

 

  • Excellent project management and negotiation skills and experience.

 

  • Analytical, with ability to assess business opportunities, however also an action oriented “driver” in order to drive the implementation.

 

Personal Characteristics:

 

  • Strong written and oral communication skills. Efficient and effective communicating with partners and senior management.

 

  • Results and goal oriented.

 

  • Ability to thrive and flourish in an entrepreneurial early stage company environment that requires “hands-on” implementation, optimal use of limited resources and an ability to work closely with others in a small team setting.

 

  • Open-minded, flexible and proactive.

 

  • Highly organized and willing to analyze details.

 

  • Ability to flourish in a fast-paced, multi-tasking and dynamic environment with a high level of ambiguity.

 

  • Willingness and capability to “roll up one’s sleeves” in order to achieve goals.

 

  • Ability to build strong relationships across a wide spectrum of internal and external parties.

 

  • Creative and innovative thinker.

 

If you are interested, please forward your resume to Sheeno Thyparambil (sheeno@mprobe.com).

mProbe – DIRECTOR, CLINICAL SALES

Company:  mProbe is a privately held company with its OncoPlex Diagnostics division focused on leveraging its Liquid Tissue® platform and enabling methods for the analysis of protein biomarkers in formalin fixed tissue and the development and commercialization of personalized medicine assays supporting cancer drug development and as clinical diagnostic assays. The company has developed a platform of proprietary technologies that make possible the accurate measurement of proteins in formalin fixed paraffin embedded (FFPE) tissue, the standard method used to preserve and store biopsies and surgical samples in medical research, clinical trials and pathology testing worldwide.    OncoPlexDx offers mass spectrometry based proprietary clinical pathology assays that is offered through its’ CAP accredited, CLIA-certified diagnostic laboratory services.

Position:  The Director, Clinical Sales will be responsible for maintaining and growing existing client business and in developing new relationships with academic institutions and community oncology practices. S/he will have a lead role in driving the sales strategies and in growing the Company’s clinical business to generate revenue. This will also be responsible for meeting monthly, quarterly and yearly sales quotas and provide customer feedback to improve OPDX products and offerings to best meet market demands.  The position will report to the CEO.

The Company’s corporate headquarter is located in California; however this position can be a remote based role.

Key responsibilities:

  • Account development – identify and cultivate targeted new accounts, follow up on leads and prospects, maintain ongoing contacts with new and existing accounts, develop specific business proposals, lead the drafting of proposals and quotations, assume primary responsibility for revenue projections and updates and internal planning and coordination with clinical operations and general management.
  • Sales – Organize web-based and in-person customer visits, seminars and proposal development meetings, drawing in and coordinating with applicable personnel in the company as well as with respect to the appropriate decision makers and support personnel at the account.
  • Strategic Planning – Develop overall strategies and tactical plans in support of revenue development within assigned responsibilities.
  • Initiate new company contacts within pharmaceutical companies as well as academic and related institutes.
  • Build and leverage existing strategic networks and business relationships. Manage customer relations/satisfaction throughout collaboration including site visits.
  • Provide a direct, “hands-on” role to identify opportunities, and create contacts and interest with senior academic investigators, community oncology practitioners and program managers.
  • Work with CEO to create and execute a business development plan and account management process with ability to project revenue growth and track progress in generating new accounts and expanding business in existing relationships.
  • Report progress on a regular basis, associated with the acquisition of new opportunities for new and existing accounts.
  • Participate in company initiatives as required for securing new business and maintaining relationships with existing clients.
  • Attend and represent OncoPlexDx at selected industry meetings and conferences.
  • While the position is expected to initially involve a significant individual contribution utilizing support from the company’s existing marketing, operations and R&D management, the individual will be expected, long term, to plan and build a team to generate and support continued business growth.

Specifications:

  • Bachelor’s degree in relevant scientific or technical discipline, advanced degree preferred (MBA and/or PhD)
  • Deep knowledge of oncology based molecular diagnostics
  • Minimum of (5) years successful sales/business development experience in complex selling environment
  • Prior successful accomplishments as the lead manager in selling oncology tests to community and academic oncologists.
  • Ability and willingness to travel approximately 50-75% of the time.
  • Solid understanding of patient care and use of diagnostic tests within the U.S. clinical market, and reimbursement systems governing clinical assays – especially CLIA laboratory services.
  • Excellent project management and negotiation skills and experience.
  • Analytical, with ability to assess business opportunities, however also an action oriented “driver” in order to drive the implementation.

 

Personal Characteristics:

  • Strong written and oral communication skills. Efficient and effective communicating with partners and senior management.
  • Results and goal oriented.
  • Ability to thrive and flourish in an entrepreneurial early stage company environment that requires “hands-on” implementation, optimal use of limited resources and an ability to work closely with others in a small team setting.
  • Open-minded, flexible and proactive.
  • Highly organized and willing to analyze details.
  • Ability to flourish in a fast-paced, multi-tasking and dynamic environment with a high level of ambiguity.
  • Willingness and capability to “roll up one’s sleeves” in order to achieve goals.
  • Ability to build strong relationships across a wide spectrum of internal and external parties.
  • Creative and innovative thinker.

If you are interested, please forward your resume to Sheeno Thyparambil (sheeno@mprobe.com).

The 5th KAPAL Annual Conference and the 11th ABES

안녕하세요.

다가오는 11월 7과 8일에 개최되는 한미 생명과학인 협회(카팔) 연례 컨퍼런스 (KAPAL Annual Conference)* 와 9일에 있을 ABES에 여러분을 초대합니다.

카팔 연례학회는 신약 연구•개발 및 상용화 관련 전문가들이 모여 신약연구 및 개발, 물질특허 및 미국 내 임상 시험에 대한 사례등의 의견을 서로 교환하고 소통하기 위한 컨퍼런스 입니다. 더불어 한국과 미국 상호간의 의 바이오 사업 추진 및 인재 채용에 적극적으로 동참하여, 양국의 바이어 산업의 무궁한 발전에 기여하기 위해 노력하고 있습니다.

카팔은 미국 정부 기관인 NIH와 FDA뿐 아니라 다수의 규모가 큰 바이오 회사가 위치한 메릴랜드의 지리적인 이점으로, 다양하게 다루어지는 바이오•신약개발 산업 관련 연구자들이 많이 참여하여 활발하게 정보 교환 및 네트워킹이 이루어지고 있습니다.

특별히 제 5 회 카팔연례학회는 아래의 주제들을 중점으로 프로그램을 준비하였습니다.

  • 미국내 임상/인허가: 세포 및 유전자 치료제 개발에 대한 미국 정부 인허가 사항 (FDA 특별세션)
  • 바이오 인공지능 및 머신 러닝: 미국 현지의 트렌드와 전략
  • 컨설팅 및 CRO 관련 분야: 미국 현지에서의 신약 개발과 임상 시 요구되는 사업전략, 임상 대행 관련 기업의 전문가들과 네트워킹
  • 로펌과 미국내 투자 및 펀딩소스

카팔연례학회는 한미 양국의 기관 및 기업의 지원을 받아, 메릴랜드 락빌에 위치한 한미 생명과학인협회 (Korean-American Professionals in Life Sciences, KAPAL) 주최로 매년 개최되고 있습니다. 자세한 내용은 행사 웹사이트(www.kapal.org/KAC)를 참조해 주시고, 질문과 건의사항은 contact@kapal.org로 문의바랍니다.

제 11회 Annual Bioscience & Engineering Symposium (ABES)

11월 9일에 개최되는 ABES는 NIH-KSA에서 준비하는 심포지엄으로, NIH 한인과학자분들의 원천기술과 연구를 발표하는 심포지엄입니다.

2019년에 이룬 다양한 생명과학분야의 연구업적등을 발표함으로써 앞으로의 혁신 신약개발의 발판이 되는 심포지엄이니 많은 관심과 참여 바랍니다. ABES 관련한 자세한 정보는 https://nihksa.org/

The KAPAL and NIH-KSA Committee

*********************************

The 5th KAPAL Annual Conference (11/7 – 8) & the 11th ABES (11/9)

You are cordially invited to the 5th KAPAL Annual Conference and the 11th ABES. Over the past four years, the conference has grown steadily, with an increasing number of participants from Korea and U.S. Last year, over 250 attendees and over 50 companies came together from multiple disciplines in the life sciences: the healthcare industry, academia, and public research institutions, such as FDA and NIH.

The KAPAL Annual Conference aims to provide business opportunities through collaboration among professionals and companies in drug development and life science. We strive to facilitate the exchange of innovative ideas and strategies for success across the healthcare industry. This year’s conference will be more informative and synergistic for the growth of US-Korea collaboration in pharmaceuticals and biotechnology.

The 5th KAPAL Annual Conference will provide opportunities to:

  • Collaborate with Korean pharmaceuticals and biotech companies
  • Expand your professional network in the Korean-American life science community
  • Develop unique perspectives on the Korean healthcare industry through keynote speakers and other presentations from leading Korean biopharmaceuticals and biotechs

You can find more information and updates at www.kapal.org/KAC. Please direct any inquiries and feedback to contact@kapal.org.

The 11th Annual Bioscience & Engineering Symposium (ABES)

NIH-Korean Scientist Association (NIH-KSA) is organizing the 11th ABES on November 9th. The ABES focuses on the fundamental research and early discovery in life science. Many exciting findings and reports are to be presented, which may become a platform of new drug development. There will be career development presentations as well to share experience and tips for all who are interested in next opportunity. For more information, refer to https://nihksa.org/

We look forward to meeting you at the 5th KAPAL Annual Conference and the 11th ABES

The KAPAL and NIH-KSA committee

* KAPAL Annual Conference was previous held as Korea-US Cooperative Conference in Life Science (한미 생명과학협력 컨퍼런스).

Samyang Biopharm (판교) – Bio, Medical Device, Toxicology 연구 & Licensing

1. 회사소개
㈜삼양바이오팜은 ㈜삼양사 의약사업부로 출발하여 2011 년 설립되었으며, 항암제와 봉합사를 중심으로 전세계 45 개국 150 여 고객에게 가치를 제공하는 의약/바이오 전문 회사입니다.
‘Value Generating Pharma Company’ 란 미래 비전을 설정하고 21 세기 핵심 분야인 의약/바이오 분야에 R&D 등 회사의 역량을 집중해 나가고 있습니다. 의약부문에서는 DDS 기반의 항암제 포트폴리오와 Biologics 관련 바이오 신약 분야를 확대할 계획입니다. MD 부문은 글로벌 핵심시장의 지속적 확대를 통해 기존 봉합사 사업의 경쟁력을 강화하고, 흡수성 소재기반의 신규 포트폴리오를 확대하고자 합니다
또한 2018 년 미국 Cambridge 에 Samyang Biopharm USA Inc.를 설립하고 면역항암제, 희귀의약품을 중심으로 미국 시장의 본격적인 진출을 추진하고 있습니다. 이는 삼양바이오팜이 지향하는 혁신적 R&D 기반의 Global 의약/바이오 회사로 성장하는 기반이 될 것입니다.

2. 모집분야

* 전 모집분야 영어능통자 필수

3. 지원방법 : 국문 혹은 영문 CV 제출. 접수처: recruit@samyang.com

오는 11/8 (금) – 9 (토) 양일간 KAC와 ABES에서 현장 인터뷰가 진행될 예정이니, 인터뷰를 원하시는 분들은 학회 전에 CV를 접수하시고, 학회에서 인터뷰 참석 여부를 알려주시기 바랍니다 (recruit@samyang.com).

4. 전형절차 : 서류전형 – 인성검사 – 1차 면접 – 2차 면접 – 채용검진 – 합격
* 외국 거주 시 화상 면접 진행 가능
5. 기 타
– 국가등록장애인 및 국가보훈 대상자는 관련 법령에 의거 우대합니다.
– 기재 내용이 허위로 판명될 경우 합격 및 입사 취소 될 수 있습니다.

채용공고문_삼양바이오팜_20191001